Veenu Aishwarya

Co-Founder

Philadelphia, Pennsylvania, United States20 yrs 9 mos experience
Most Likely To SwitchHighly Stable

Key Highlights

  • Founder of two biotechnology companies.
  • Award-winning researcher in cancer biology.
  • Expert in personalized medicine and genomics.
Stackforce AI infers this person is a Healthcare Innovator specializing in Biotechnology and Genomics.

Contact

Skills

Core Skills

BiotechnologyEntrepreneurshipGenomicsCancer BiologyResearchBusiness DevelopmentStrategyNucleic Acid Therapeutics

Other Skills

Molecular BiologyLeadershipPersonalized MedicineAntisense TechnologyMarketingPublicationClinical TrialsStrategic PlanningCorporate DevelopmentTranslational ResearchPre-clinical StudiesOncologyDrug Discovery & DevelopmentBusiness Strategy & DevelopmentCorporate - Strategy

About

I run a small business. I am blessed to be learning every day. Our goal is to help the biomedical research community advance their research, work towards finding cures for diseases, and improve human health. We also work on the development of next generation RNA targeting therapies. Our motto is: Failure can be an option. Quitting is Not. We are Hiring: We are looking for passionate and highly motivated researchers and innovators who wish to have a front row seat to invent the future of medicine. It will be challenging but at the same time it will be fun and extremely gratifying. Successful candidates will have the opportunity to grow and advance their professional and personal life with the company and work towards a shared mission. If you want to go fast, go alone. If you want to go far, go together. In the interest of saving precious lives by therapeutic innovation we need to go both Fast and Far. Send me a note if you are interested to be a part of our team.

Experience

Aum biotech

Founder and Chief Executive Officer

Jan 2015Present · 11 yrs 2 mos · Greater Philadelphia Area · On-site

  • AUM BioTech is an American Biotechnology company focused on the development of next generation of innovative genomics tools in the area of gene silencing and regulation for biomedical research. Our next generation genetic research tools are globally being used by biomedical scientists and researchers working on basic, transitional and pre-clinical research.
BiotechnologyMolecular BiologyEntrepreneurshipLeadershipGenomicsNucleic Acid Therapeutics

Aum lifetech

Founder and Chief Executive Officer

Jan 2013Present · 13 yrs 2 mos · Greater Philadelphia

  • AUM LifeTech is an American Biotechnology company focused on the development of personalized medicine at the genetic level. AUM has developed the next generation of genomics tools in the area of gene silencing and regulation. Our innovative technology has applications in treating genetic disorders by development of Nucleic Acid Therapeutics based Precision Medicine. AUM LifeTech's goal is therapeutic innovation leading to a medical revolution for a better life.
BiotechnologyMolecular BiologyEntrepreneurshipLeadershipGenomicsPersonalized Medicine+1

The wharton school

Program participant

Jan 2013Jan 2013 · 0 mo

  • Participated in a business building program (@ Wharton Entrepreneurship) with a focus on the following key aspects:
  • 1) Business development and strategy
  • 2) Revenue models and cash flow
  • 3) Operations management
  • 4) Strategic alliances
  • 5) Marketing
Business DevelopmentStrategyMarketing

Perelman school of medicine, university of pennsylvania

2 roles

Research

Apr 2011Jan 2013 · 1 yr 9 mos · Philadelphia, PA

  • Research

Visiting Scholar

Apr 2009Mar 2011 · 1 yr 11 mos · Philadelphia, PA

  • ๏ Invited book chapter:
  • Invited to write a chapter* in Springer's special volume - "Nucleic Acid Drugs". This book is a special edition and exclusively contains invited chapters from scientific leaders (in their respective fields) from across the world both from academia and industry.
  • This invited article entails latest data and thoughts on the development & clinical applications of Nucleic Acid Therapeutics. *Also the corresponding and first author for this article.
  • ๏ Book chapter (indirect invitation):
  • Wrote a chapter in Springer's book - "RNA technologies and their application".
  • The article entails data and thoughts on mRNA structure and its effect on post transcriptional gene silencing.
  • ๏ Research:
  • Worked on strategies to enhance siRNA delivery, stability and reduce off target effects in cell lines and hematopoietic stem cells (joint work published in the journal - Nucleic Acids Research; impact factor 13.1).
  • Assisted my mentor in reviewing research articles and to write NIH research grants

Temple university

Visiting Research Scholar

Apr 2011Jul 2013 · 2 yrs 3 mos · Philadelphia, PA

  • • Work on antisense technology and cancer biology led to the competitive & prestigious Young Scientist Award by the reputed Keystone Symposia in the form of - "Future of Science Fund Scholarship" for exceptional innovative research. The award was given in January, 2012
Antisense TechnologyCancer BiologyResearch

Ggsip university

4 roles

Voluntary Research

Promoted

Jan 2007Jan 2009 · 2 yrs · Delhi, India

  • ๏ Work on microsatellites (junk DNA) led to a first author publication in the journal - Nucleic Acids Research (impact factor - 13.1).
  • ๏ Assisted in reviewing research articles
Nucleic Acid TherapeuticsResearch

Teaching assistant

Promoted

Jan 2006May 2006 · 4 mos · Delhi, India

  • Teaching assistant in Bio-analytical Techniques
  • Assisted practical classes which involved graduate level genomics, recombinant DNA Technology and bioprocess engineering
ResearchPublication

Teaching assistant

Aug 2005Dec 2005 · 4 mos · Delhi, India

  • Teaching assistant in Genetics
  • Assisted practical classes with graduate level genetics

Research

Jan 2005Dec 2006 · 1 yr 11 mos · Delhi, India

  • ๏ Work on microsatellites (junk DNA) led to two publications in the following journals:
  • BMC Genomics (first author; impact factor 4.07).
  • Molecular Genetics and Genomics (second author; impact factor 2.635).
  • Work on microsatellites (junk DNA) led to a first author publication in the journal - Nucleic Acids Research (impact factor - 13.1).
  • ๏ Assisted in reviewing research articles
ResearchPublication

Education

Educated Enough to Make a Difference

The Wharton School

Business Building Program Workshops @ Wharton Entrepreneurship

Jan 2013Jan 2013

GGSIP University, Delhi, India

M.Tech (Engineering) — Biotechnology

Jan 2005Jan 2006

GGSIP University, Delhi, India

B.Tech (Engineering) — Biotechnology

Jan 2001Jan 2005

Stackforce found 100+ more professionals with Biotechnology & Entrepreneurship

Explore similar profiles based on matching skills and experience